Drug Profile
Oxcarbazepine extended release - Spherics
Alternative Names: SRx-504Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Spherics
- Class Antiepileptic drugs; Dibenzazepines; Mood stabilisers; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Epilepsy
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Epilepsy in USA (PO, Capsule)